Gene Query: ALMS1

Dataset Description Geneva Score
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 45.27
LncRNA-GAS5 negative regulation of YAP-target genes expression 38.19
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 34.63
Impact of dieldrin on transcription in Jurkat T cells 28.38
Human cell line and subcutaneous tumor 26.93
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 26.63
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 24.97
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 23.84
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 22.97
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 22.2
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 22.2
Human embryonic stem cells in E8 and AKIT culture medium 21.76
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 21.76
Genes significantly down or Up-regulated upon RNF219 knockdown 21.55
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 21.44
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 21.44
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 20.46
hTERT promotes cell adhesion and migration independent of telomerase activity 19.79
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 17.86
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 17.85
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 17.43
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 16.98
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 16.81
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 16.3
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 15.98
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 15.65
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 15.58
High-throughput sequencing of PROMPT-enriched samples. 15.47
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 15.21
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 15.01
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 15.0
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 14.94
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 14.81
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 14.8
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 14.77
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 14.74
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 14.34
Global Mapping of Human RNA-RNA Interactions 14.24
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 14.2
Transcriptomic analyssis following EHMT1/2 inhibition 13.99
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 13.88
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 13.88
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 13.82
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 13.63
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 13.33
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 13.23
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 13.09
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 12.98
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 12.88
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 12.8
Differential Gene Expression between MCF10A and MCF7 cells 12.75
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 12.5
Stem and effector CD8 T-cells from human cancers 12.47
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 12.37
NRDE2 negatively regulates nuclear exosome functions 12.36
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 12.35
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 12.07
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 11.94
Zika infected neural stem cells 11.84
Transcriptome analysis of Zika infected neural stem cells 11.84
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 11.8
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 11.78
Tyrosine Kinase Inhibitor Cardiotoxicity 11.69
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 11.69
Role of XRN2 ribonucleolytic activity in RNA metabolism 11.68
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 11.66
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 11.63
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 11.55
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 11.54
3’ Uridylation Expands miRNA Target Repertoire 11.46
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 11.36
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 11.27
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 11.26
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 11.14
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 11.14
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 11.13
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 11.12
10.83
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 10.73
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 10.72
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 10.7
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 10.6
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 10.54
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 10.49
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 10.47
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 10.47
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 10.3
Gene expression changes caused by KRAS in MCF-10A 10.25
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 10.2
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 10.2
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 10.17
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 10.17
TT-Seq captures the human transient transcriptome 10.05
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 10.03
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 10.03
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 9.97
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 9.9
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 9.88
TGF-β regulation of miRNA expression in pancreatic cancer 9.8
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 9.75
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 9.75
EWS-Fli and LNC regulated genes in comparison to GFP samples 9.73
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 9.62
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 9.57
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 9.57
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 9.55
The age and genomic integrity of neurons after cortical stroke in humans 9.54
The contribution of Alu exons to the human proteome 9.54
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 9.51
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 9.5
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 9.42
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 9.29
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 9.27
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 9.23
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 9.23
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 9.19
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 9.19
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 9.17
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 9.17
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 9.14
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 9.14
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 9.14
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 9.11
Expression and functions of long noncoding RNAs during human T helper cell differentiation 9.06
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 9.05
RNA transcriptome analysis during HSV-1 infection 9.0
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 8.85
SNHG5 siRNA knock down in HCT116 cells 8.79
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 8.78
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 8.77
Systematic discovery of endogenous human ribonucleoprotein complexes 8.69
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 8.69
The cohesin release factor WAPL restricts chromatin loop extension. 8.69
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 8.67
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 8.65
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.62
Differentially expressed vascular development genes for iPSC-ECs from CDI 8.62
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 8.61
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 8.56
U1 snRNP telescripting regulates size-function stratified human genome 8.5
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 8.49
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 8.49
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 8.35
Transcriptome analysis of human lung epithelial cells 8.35
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 8.34
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 8.33
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 8.33
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 8.3
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 8.25
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 8.24
Recovery and analysis of nascent RNA 8.24
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 8.21
RIG-I and MDA5 fRIP during KSHV lytic reactivation 8.19
RNA-sequencing in irradiated and normal A549 cells. 8.14
The comparison of high-throughput single-cell RNA-seq methods 8.12
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 8.03
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 7.98
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 7.98
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 7.93
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 7.89
Differentiation enhances Zika virus infection in neuronal brain cells 7.88
The Genomic Landscape of Atypical Fibroxanthoma 7.81
Nucleoporin-mediated regulation of cell identity genes 7.76
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 7.64
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 7.64
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 7.64
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.59
Expression profiling of etoposide-induced senescent cells 7.55
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 7.55
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 7.55
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 7.53
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 7.52
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 7.52
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 7.51
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 7.5
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 7.47
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 7.46
The evolution of N6-methyladenosine in primates 7.43
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 7.42
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 7.41
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 7.4
Differentially expressed genes post knock down of lincDUSP26 7.39
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 7.38
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 7.38
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 7.35
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 7.35
Regulation of poly(A) tail and translation during the somatic cell cycle 7.29
MYC dependent mRNA translation shapes gene expression and cell biology 7.27
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 7.23
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 7.22
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 7.22
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 7.2
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 7.18
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 7.18
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 7.1
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 7.09
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 7.07
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 7.03
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.0
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 6.95
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 6.95
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 6.95
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 6.94
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 6.94
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 6.89
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 6.89
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 6.89
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 6.87
Functional Haploid Human Oocytes Generated from Polar Body Genomes 6.87
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 6.86
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.86
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 6.8
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 6.78
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 6.75
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 6.75
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 6.73
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 6.71
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 6.69
RNA-seq analysis to identify the genes regulated by p53-SET interplay 6.64
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 6.61
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 6.61
Gene expressions of H9s in different culture systems 6.58
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 6.57
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 6.52
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 6.52
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 6.51
Generation of KRAS signatures using immortalized isogenic lung cells. 6.48
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 6.4
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 6.35
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 6.31
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 6.31
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 6.28
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.27
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 6.27
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 6.24
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.22
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 6.21
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 6.21
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 6.19
Cerebellar differentiation in Ataxia-Telangiectasia 6.17
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 6.13
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 6.13
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 6.1
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 6.09
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 6.06
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 6.03
RNA editing in nascent RNA affects pre-mRNA splicing 6.03
AMPK signaling for naïve pluripotency 6.01
AMPK signaling for naïve pluripotency [Hs] 6.01
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.99
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.99
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 5.98
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 5.97
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 5.96
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.94
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 5.93
Universal alternative splicing of noncoding exons 5.85
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 5.8
Fibroblasts in cholesteatoma activate osteoclasts. 5.76
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 5.65
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 5.61
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 5.59
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 5.54
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 5.53
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 5.52
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.47
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 5.43
BASP1 modifies the Tamoxifen response 5.43
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 5.42
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 5.35
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 5.35
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 5.35
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 5.34
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 5.33
The conserved transcriptional landscapes in human spermatogenesis 5.27
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 5.27
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 5.24
mRNA-sequencing of breast cancer subtypes and normal tissue 5.15
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 5.15
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.14
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 5.11
HEK293 Heat-shock experiment 5.06
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 5.05
Microprocessor mediates transcription termination in long noncoding microRNA genes 5.04
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.02
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.01
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.01
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.99
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 4.98
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 4.93
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 4.93
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 4.86
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 4.86
Patient-derived xenograft platform for metastatic melanoma 4.79
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.79
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.72
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.72
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 4.72
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 4.67
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 4.67
Transcriptome analysis of CNS leukemia 4.64
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.64
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 4.51
Downregulation of DDX5/DDX17 and REST 4.49
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 4.48
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 4.46
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 4.37
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 4.36
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 4.34
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 4.25
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 4.2
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.18
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 4.17
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.13
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 4.13
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.13
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.08
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 4.06
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.05
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 4.01
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 4.01
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 4.01
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.0
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.98
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.98
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.96
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 3.96
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 3.95
Role of COP1 on MAP kinase transcriptional output in melanoma 3.91
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.88
Intron retention induced by microsatellite expansions as a disease biomarker. 3.85
mRNA expression profile of Lymphocytes 3.84
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 3.76
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.74
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.73
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.73
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 3.71
Gene expression profile in breast cancer cells 3.67
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.67
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 3.66
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 3.64
RNA-seq melanoma 3.61
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 3.61
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.61
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 3.59
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 3.57
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.38
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.33
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 3.31
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.31
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 3.3
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.29
Targeted enhancer activation by a subunit of the integrator complex 3.28
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 3.24
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 3.24
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 3.22
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.16
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 3.14
mRNA expression profile of Lymphocytes by high-throuput sequencing 3.11
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 3.09
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 3.01
Function and hormonal regulation of GATA3 in human first trimester placentation 2.99
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.99
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.99
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 2.97
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.95
Gene expression changes after LOC550643 silencing 2.94
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.93
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.92
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 2.89
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.84
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.81
RNA seq comparison between scrambled and shGRP78 cells 2.81
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.79
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.79
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.79
mRNA recovered upon RNF219 IP. [RNA-IP] 2.74
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.74
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.72
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.71
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.65
Functional significance of the HIV-1 Tat signature amino acid residues 2.64
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.55
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.55
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.53
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.52
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.51
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.51
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 2.49
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.47
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.39
Transcriptomic profiling of human peripheral blood-derived mast cells 2.36
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 2.36
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.32
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.32
Aortic Valve Tissue: Stenosis vs. Sclerosis 2.3
WNT signaling memory is required for ACTIVIN to function as a morphogen 2.26
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.24
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.24
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 2.22
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.21
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.21
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.19
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.09
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.06
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.05
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 2.01
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 1.97
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.96
RNA-seq analysis of control and Myc-induced U2OS cells 1.93
MYCL and EP400 are required for Max and MCPyV mediated gene activation 1.91
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.89
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.89
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.88
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.88
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.88
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.81
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.81
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.81
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.78
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.78
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.76
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.76
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.62
Gene expression analysis of human adenomas. 1.59
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.53
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.5
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.45
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.44
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.43
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.41
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.39
Gene expression analysis of human hepatocellular cancers 1.39
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.39
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.39
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.37
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.36
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.36
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.3
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.27
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.27
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 1.26
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.25
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.18
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.18
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.15
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 1.12
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 1.1
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.08
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.08
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.07
Transcriptomes in healthy and CHB fetal hearts 1.04
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.04
Transcriptome analysis reveals differential splicing events in IPF lung tissue 1.03
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 1.01
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.0
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 1.0
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.96
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.96
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.95
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 0.86
JunB control of keratinocyte-mediated inflammation [RNA-seq] 0.86
RNA-seq of primary patient AML samples 0.85
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.78
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.75
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.75
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.73
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.72
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.71
Aging-associated patterns in the expression of human endogenous retroviruses 0.7
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.69
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.67
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 0.66
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.63
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.61
m6A-dependent regulation of messenger RNA stability 0.6
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.55
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.55
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.55
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.53
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.44
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.42
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.42
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.42
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.41
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.34
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.31
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.28
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.28
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 0.28
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.25
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.25
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.23
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.21
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.19
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.19
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.15
Modulation of nonsense-mediated decay by rapamycin 0.11
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation